190 studies found for:    Open Studies | "Urinary Bladder Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urinary Bladder Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer
Conditions: Bladder Cancer;   Cancer;   Bladder Neoplasms;   Urinary Bladder Cancer
Intervention:
2 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
3 Recruiting Safety and Efficacy Study of Cancer Immunotherapeutic MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
Condition: Urinary Bladder Neoplasms
Interventions: Biological: recMAGE-A3 + AS15 ASCI;   Biological: Placebo
4 Recruiting Adjuvant Radiation for High Risk Bladder Cancer
Conditions: Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Radiation: 3D conformal radiation therapy;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
5 Recruiting Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: Erlotinib Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Procedure: Therapeutic Conventional Surgery
6 Recruiting Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Drug: Sirolimus;   Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Procedure: Therapeutic Conventional Surgery;   Other: Laboratory Biomarker Analysis
7 Unknown  Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: robot-assisted laparoscopic surgery;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery
8 Recruiting Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery
Conditions: Bladder Urothelial Carcinoma;   Recurrent Bladder Carcinoma;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Drug: Eribulin Mesylate;   Drug: Gemcitabine Hydrochloride
9 Recruiting A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Condition: Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms
Intervention: Drug: MPDL3280A
10 Not yet recruiting Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer
Conditions: Urinary Bladder Neoplasms;   Sexual Dysfunction, Physiological;   Sexual Dysfunctions, Psychological;   Erectile Dysfunction;   Hematuria
Intervention: Other: EORTC QLQ-C30 and EORTC BLS-24 questionnaire
11 Unknown  Quality of Life in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: quality-of-life assessment;   Procedure: questionnaire administration
12 Unknown  Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: biopsy;   Procedure: chemoprevention;   Procedure: cryopreservation;   Procedure: cytology specimen collection procedure;   Procedure: diagnostic procedure;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: medical chart review;   Procedure: mutation analysis;   Procedure: polymerase chain reaction;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
13 Recruiting 3 Tesla MRI in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: Specimen Ultra-High field MRI;   Drug: chemotherapy;   Procedure: Cystectomy and Lymphadenectomy
14 Unknown  Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: medical chart review;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
15 Unknown  Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: chemoprevention
16 Unknown  A Study for Treatment of Superficial Bladder Cancer Using OGX-427
Condition: Bladder Cancer
Intervention: Drug: OGX-427
17 Unknown  Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Dietary Supplement: selenium;   Other: placebo
18 Unknown  Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: sorafenib tosylate;   Other: imaging biomarker analysis;   Other: laboratory biomarker analysis;   Procedure: computed tomography;   Procedure: neoadjuvant therapy;   Radiation: fludeoxyglucose F 18
19 Recruiting Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin
Conditions: Invasive Bladder Cancer;   Bladder Cancer
Intervention: Drug: Gemcitabine and fractionated cisplatin (combination treatment)
20 Not yet recruiting MK-3475/BCG in High Risk Superficial Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: Intravenous MK-3475/ Intravesical BCG

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years